1. C.5 Musashi-1 is a master regulator of aberrant translation in MYC-amplified Group 3 medulloblastoma. (November 2021) Authors: Kameda-Smith, MM; Zhu, H; Luo, E; Venugopal, C; Brown, K; Yee, BA; Xing, S; Tan, F; Bakhshinyan, D; Adile, AA; Subapanditha, M; Picard, D; Moffat, J; Fleming, A; Hope, K; Provias, J; Remke, M; Lu, Y; Reimand, J; Wechsler-Reya, R Journal: Canadian journal of neurological sciences Issue: Volume 48(2021)Supplement S3 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Host MyD88 signaling protects against acute graft-versus-host disease after allogeneic bone marrow transplantation. (14th October 2018) Authors: Xing, S; Zhang, X; Liu, J H; Huang, X; Zhou, P Journal: Clinical and experimental immunology Issue: Volume 195:Number 1(2019) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Serum sMICA as biomarker in detection of non-small-cell lung carcinoma. Issue 1 (2nd January 2018) Authors: Xing, S; Zhu, Y; Sun, Y Journal: British journal of biomedical science Issue: Volume 75:Issue 1(2018) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗